Evidence map›Paper›PMID 30858391›Full record

ArticleScientific reports2019

USP18 and ISG15 coordinately impact on SKP2 and cell cycle progression.

Françoise Vuillier, Zhi Li, Pierre-Henri Commere, Lasse Toftdal Dynesen, Sandra Pellegrini

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
2.1field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 44 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Melatonin Alleviates Oxidative Stress Induced by HAntioxidants (Basel, Switzerland) · 2022
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Françoise VuillierInstitut Pasteur, Unit of Cytokine Signaling, Inserm U1221, 75724, Paris, France.
Zhi LiInstitut Pasteur, Unit of Cytokine Signaling, Inserm U1221, 75724, Paris, France.
Pierre-Henri CommereInstitut Pasteur, Flow Cytometry Platform, 75724, Paris, France.
Lasse Toftdal DynesenInstitut Pasteur, Unit of Cytokine Signaling, Inserm U1221, 75724, Paris, France.ORCID 0000-0003-3881-7131
Sandra PellegriniInstitut Pasteur, Unit of Cytokine Signaling, Inserm U1221, 75724, Paris, France. sandra.pellegrini@pasteur.fr.ORCID 0000-0001-5837-7589
Inserm · FRInstitut Pasteur · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

USP18 is an isopeptidase that cleaves the ubiquitin-like ISG15 from conjugates and is also an essential negative feedback regulator of type I interferon signaling. We and others reported that USP18 protein is stabilized by ISG15 and targeted for degradation by SKP2 (S-phase kinase associated protein 2), the substrate-recognition subunit of the SCF

Indexed as

Cell CycleCytokinesHeLa CellsHumansImmunity, InnateSignal TransductionS-Phase Kinase-Associated ProteinsUbiquitinUbiquitinsUbiquitin ThiolesteraseCytokinesISG15 protein, humanSKP2 protein, humanS-Phase Kinase-Associated ProteinsUbiquitinUbiquitinsUbiquitin ThiolesteraseUSP18 protein, human

Identifiers

PMID30858391
PMCPMC6411882
OpenAlexW2922420878

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.